When a finance team misses quarterly targets, there's an investigation.
When sales misses target, there's a different conversation.
The finance miss triggers root cause analysis. Process audits. Questions about what controls failed and what needs to change. The dysfunction gets named, measured, and addressed.
But when sales misses target (which, in 2023, happened to 72% of sales representatives), the response follows a familiar script. Talk of "headwinds." Market conditions. The need for more opportunities. And because sales has always been unpredictable, the explanation gets accepted. That's just the nature of the beast.
Except it isn't. And the mounting evidence suggests we've been accepting a dysfunction that would be considered catastrophic in any other part of the business.
In 2012, 74% of sales representatives met their target. By 2023, that figure had collapsed to just 28%. A 62% decline in eleven years. This isn't a blip. This isn't a cyclical downturn. This is systematic degradation of sales effectiveness across the entire B2B landscape.
And yet, in most boardrooms, sales underperformance is treated as background noise rather than a structural crisis.
If an operations team had an 87% failure rate, most companies would shut down production until they found the problem. If a finance team miscalculated 87% of their forecasts, there would be regulatory scrutiny. But sales? Sales gets another motivational speech and a new CRM feature.
The dysfunction runs deeper than target attainment. Win rates, the fundamental measure of sales effectiveness, now sit between 17% and 21%. That represents a 27% decline since 2021. Translation: sales teams are losing four out of five opportunities they pursue. And unlike target attainment, which can be gamed by adjusting targets, win rates don't lie about competitive effectiveness.
Here's where the story gets expensive.
Sales rep turnover runs at 35%, nearly three times the average for other roles. The average rep stays just 18 months, despite data showing peak performance doesn't occur until years two and three. Companies lose people right when they become valuable.
The replacement cost when onboarding fails? £97,960 on average. For high performers, it exceeds £200,000. And with 88% of companies admitting their onboarding is subpar, most organisations are paying that cost far more often than the P&L reveals.
But the real cost isn't the hiring expense—it's the revenue impact of perpetually under-skilled sales teams. With average ramp time now at 5.7 months (up 32% since 2020), every new hire represents nearly half a year of near-zero productivity. In a business with 35% annual turnover, teams are always rebuilding. They never achieve the compounding returns of experienced, high-performing salespeople.
Imagine a COO walking into a board meeting with these metrics:
That COO would be asked, very directly: "What's broken? What are we measuring? What are we changing?"
Sales leaders present identical metrics and get asked: "What can we do to help?"
This is the dysfunction nobody talks about. Not the poor performance itself (that's obvious to anyone reading the quarterly results), but the organisational double standard that treats sales underperformance as unavoidable rather than unacceptable.
The standard defence is that sales operates in a uniquely complex environment. And there's truth in that. The B2B buying landscape has become genuinely harder. The average purchase now involves 13 stakeholders, up from 6.8 in 2017. Nearly 90% of buying decisions cross multiple departments. And here's the kicker: 61% of lost deals aren't lost to competitors—they're lost to buyer indecision.
These are real challenges. But they don't explain why sales is the only function exempt from diagnostic measurement.
Marketing teams operate in complex environments too. Algorithm changes, platform fragmentation, constantly shifting buyer behaviour. But organisations still measure cost per acquisition, conversion rates, and attribution. They know what's working and what isn't because they've built the infrastructure to measure it.
Product teams face complexity: technical debt, feature prioritisation, cross-functional dependencies. But companies measure velocity, deployment frequency, and defect rates. They know whether they're improving because they've defined what improvement looks like.
Sales? Sales measures activity (calls made, emails sent) and outcomes (deals closed, revenue generated). But the massive gap in between—the actual sales capability, the quality of buyer interactions, the effectiveness of the sales process—remains fundamentally unmeasured.
This statistic deserves its own paragraph. The people responsible for developing, coaching, and supporting sales teams are underperforming in 45% of cases. And unlike individual rep performance, manager performance has a multiplier effect. When a rep underperforms, one person's revenue suffers. When a manager underperforms, the entire team's potential is lost.
Gartner's research shows that managers backed by organisational support (the right technology, systems, and cross-functional collaboration) are 5.9x more likely to have strong team performance. Not 59% more likely. Nearly six times more likely. The infrastructure exists to dramatically improve sales outcomes. Most organisations just haven't built it.
The current state creates a strange equilibrium where everyone quietly accepts that sales doesn't work very well, but nobody wants to say it out loud.
CEOs know the sales forecast is essentially fiction but don't have better data to work with. CFOs build in a "sales achievement discount" when modelling revenue. Boards expect misses and get them. Sales leaders rotate through every three years, each one inheriting the same structural problems and leaving before anyone notices they haven't fixed them.
Meanwhile, businesses keep investing. More technology (60% of sales teams now use GenAI, though only one-third see productivity gains). More training programmes (which reps forget within weeks without reinforcement infrastructure). More "enablement" resources (that sales managers don't have time to use because they're too busy firefighting).
None of it works because none of it addresses the core dysfunction: you cannot improve what you do not measure.
Here's what's most telling. When sales underperforms, the conversation is always about what sales needs more of. More leads. More marketing support. More competitive intelligence. More training. More headcount.
The conversation is never: "What are we measuring wrong? What should we be measuring that we're not? What does good actually look like in a way we can observe and replicate?"
Because answering those questions would require admitting that the emperor has no clothes. That the quarterly ritual of forecasting, missing, explaining, and adjusting isn't actually management—it's theatre.
And once that becomes clear, there's no going back. The 28% target attainment can't be explained away as "just how sales is." The 17% win rates can't be blamed on market conditions. The 35% annual turnover can't be called normal.
The dysfunction becomes visible. And visible dysfunctions demand solutions.
Part 2: Why Sales Is Different (And Why That's Not An Excuse)
Yes, B2B sales faces unique challenges. But "uniquely challenging" and "unmeasurable" aren't the same thing. We'll examine what actually makes sales different—and why those differences demand better measurement, not an exemption from it.
This is a 5-part series. Subscribe and each new post arrives automatically in your inbox—no hunting through LinkedIn or waiting for algorithms.
The 12 questions that reveal what's really broken in your sales function. These aren't surface-level—they force you to confront what you actually know versus what you assume.
No spam. One email per post. Unsubscribe anytime.